These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9711995)

  • 1. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Miyaguchi S; Takahashi K; Toyota T
    Metabolism; 1998 Aug; 47(8):977-81. PubMed ID: 9711995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Sakata Y; Muto G; Muto Y; Takahashi K; Toyota T
    Diabetologia; 1998 Nov; 41(11):1321-6. PubMed ID: 9833940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine.
    Sagara M; Satoh J; Wada R; Yagihashi S; Takahashi K; Fukuzawa M; Muto G; Muto Y; Toyota T
    Diabetologia; 1996 Mar; 39(3):263-9. PubMed ID: 8721770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats.
    Attia HN; Al-Rasheed NM; Al-Rasheed NM; Maklad YA; Ahmed AA; Kenawy SA
    Behav Pharmacol; 2012 Apr; 23(2):153-61. PubMed ID: 22411174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats.
    Aggarwal M; Singh J; Sood S; Arora B
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):131-4. PubMed ID: 11523311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
    Naka K; Sasaki H; Kishi Y; Furuta M; Sanke T; Nanjo K; Mukoyama M
    Diabetes Res Clin Pract; 1995 Dec; 30(3):153-62. PubMed ID: 8861454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Effects of Prophylactic and Therapeutic Administrations on Peripheral Neuropathy in Streptozotocin-Diabetic Rats with Gliclazide or Methylcobalamin.
    Yao H; Feng J; Zheng Q; Wei Y; Yang G; Feng W
    Exp Clin Endocrinol Diabetes; 2020 Oct; 128(10):635-643. PubMed ID: 30453342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.
    Suh KS; Oh SJ; Woo JT; Kim SW; Yang IM; Kim JW; Kim YS; Choi YK; Park IK
    Korean J Intern Med; 1999 Jul; 14(2):34-40. PubMed ID: 10461423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.
    Abdelkader NF; Eitah HE; Maklad YA; Gamaleldin AA; Badawi MA; Kenawy SA
    Life Sci; 2020 Apr; 247():117458. PubMed ID: 32092333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats.
    Yagihashi S; Kamijo M; Baba M; Yagihashi N; Nagai K
    Diabetes; 1992 Jan; 41(1):47-52. PubMed ID: 1727739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy.
    Wada R; Nishizawa Y; Yagihashi N; Takeuchi M; Ishikawa Y; Yasumura K; Nakano M; Yagihashi S
    Eur J Clin Invest; 2001 Jun; 31(6):513-20. PubMed ID: 11422401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroprotective effects of progesterone on experimental diabetic neuropathy in rats.
    Sameni HR; Panahi M; Sarkaki A; Saki GH; Makvandi M
    Pak J Biol Sci; 2008 Aug; 11(16):1994-2000. PubMed ID: 19266905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
    Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG; Kumar A; Sharma SS
    Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat.
    Bravenboer B; Kappelle AC; Hamers FP; van Buren T; Erkelens DW; Gispen WH
    Diabetologia; 1992 Sep; 35(9):813-7. PubMed ID: 1397775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lacidipine pre-treatment on diabetic neuropathy in rats.
    Singh J; Aditya S; Lal H; Arora B
    Arch Physiol Biochem; 2011 Feb; 117(1):12-7. PubMed ID: 21091185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.